This Article Full Text (PDF) Correction (v43,p502) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by STONE, N. Articles by LOWN, B. Search for Related Content PubMed PubMed Citation Articles by STONE, N. Articles by LOWN, B.

(Circulation. 1971;43:420.)
© 1971 American Heart Association, Inc.

---

Diphenylhydantoin in the Prevention of Recurring Ventricular Tachycardia

NEIL STONE M.D.¹; MICHAEL D. KLEIN M.D.¹; BERNARD LOWN M.D.¹

¹ From the Cardiovascular Research Laboratories, Department of Nutrition, Harvard School of Public Health, and the Medical Clinics of the Peter Bent Brigham Hospital, Boston, Massachusetts.

The efficacy of diphenylhydantoin in preventing recurrent ventricular tachycardia was studied in ten patients, nine of whom had documented coronary heart disease. Prolonged continuous ECG monitoring of up to 72 hr was performed in each case. Oral and intravenous loading doses of 1000 to 1500 mg were given on the first day of therapy to insure rapid attainment of therapeutic blood levels. Diphenylhydantoin was uniformly ineffective in preventing recurrence of ventricular tachycardia despite the presence of what is regarded as adequate therapeutic plasma concentrations (greater than 19.0 µg/ml in five patients, 10.8-18.0 µg/ml in the remaining five) shortly after onset of ventricular tachycardia. Nystagmus was noted in eight patients, but plasma diphenylhydantoin levels varied widely (8.6-35.0 µg/ml) when this sign of neurotoxicity was first detected.

Key Words: Coronary heart disease • Myocardial infarction • Nystagmus • Sudden cardiac death

Submitted on October 14, 1970
Accepted on December 1, 1970

This article has been cited by other articles:

				E. G. Abinader and M. Cooper Mexiletine: Use in Control of Chronic Drug-Resistant Ventricular Arrhythmia JAMA, July 27, 1979; 242(4): 337 - 339. [Abstract] [PDF]

				R. A. WINKLE, E. L. ALDERMAN, J. W. FITZGERALD, and D. C. HARRISON Treatment of Recurrent Symptomatic Ventricular Tachycardia Ann Intern Med, July 1, 1976; 85(1): 1 - 7. [Abstract] [PDF]

				J. Koch-Weser Antiarrhythmic Prophylaxis in Ambulatory Patients With Coronary Heart Disease Arch Intern Med, May 1, 1972; 129(5): 763 - 772. [Abstract] [PDF]